Uchicago Argonne, LLC

Lemont, IL Professional servicesNAICS 541700

Self-funded health planPlan year 2025Renews January
4,159Participants+7% vs. prior year
$9.9MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#4 of 44Professional services in ILBy participants

Overview

Uchicago Argonne, LLC sponsors a self-funded health plan that covered 4,159 participants in plan year 2025, up 7% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, long-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
4,159 · prior year 3,896
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Argonne National Laboratory Master Welfare Plan, plan 501 (4,159 participants); Argonne Retiree Health Reimbursement Account, plan 533 (2,029 participants)
Broker compensation
$71K across insured contracts
MedicalLife insuranceDentalVisionLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Life Insurance Company of North America (life Insurance)Life3,228$1.4M$36K
Unum Life Insurance Company of America (long Term Disability)Long-term disability3,051$1.1M$24K
Eyemed Vision CareVision6,277$388K$4K
Life Insurance Company of North America (accidental Death)Life3,490$177K$5K
Life Insurance Company of North America (business Travel Accident)Business Travel Accident/accidental Deat3,770$272$187

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$9.9M/ year

Estimated prescription spend: 4,159 participants × $2,371 national average per member. Usually higher once dependents are counted.

$256K–$632K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$75K–$187K
Lower-cost therapeutic alternatives$109K–$229K
Generic pricing vs. actual cost$47K–$142K
PBM contract terms$25K–$74K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Uchicago Argonne, LLC
Sponsor EIN
68-0628477
Plan numbers
501, 533
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 68-0628477 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Argonne National Laboratory 403(b) Employee Retirement Plan
Type
Defined contribution plan
Participants
7,417

About this data

Source: Uchicago Argonne, LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Uchicago Argonne, LLC.

Request a correction · Methodology